Traphaco is steadfast in its strategy of combining Eastern medicine

Traphaco's strategy of developing two parallel product lines of high-quality oriental medicine and high-quality modern medicine is not only a breakthrough in the business model, but also a typical example of the philosophy of sustainable innovation, integrating international standards of quality and social responsibility.

Traphaco is steadfast in its dual strategy of Eastern and Western medicine.

Traphaco's strategy of developing two parallel product lines of high-quality oriental medicine and high-quality modern medicine is not only a breakthrough in the business model, but also a typical example of the philosophy of sustainable innovation, integrating international standards of quality and social responsibility.

Ms. Dao Thuy Ha, Deputy General Director of Traphaco Joint Stock Company, representing the Company to receive the Top 10 Sustainable Development Enterprises Award - CSI 2023

Over the past 50 years, Traphaco Joint Stock Company has made a solid mark in the Vietnamese pharmaceutical market with successes in manufacturing and distributing medicinal products from the country's rich natural resources.

Through the parallel development strategy of high-quality oriental medicine products and high-quality modern medicine, Traphaco has been and is continuing to affirm its position in the domestic market, while preparing to enter the international market with high-quality products and unique cultural values ​​from Vietnamese medicinal herbs.

Innovation for sustainable development

Since its inception, Traphaco has pursued a philosophy of sustainable development by preserving and promoting the value of domestic medicinal resources. This is part of the strategy of accompanying the community and the environment, helping to create jobs and increase income for local people, especially in remote areas. This strategy was initiated by GreenPlan - a project aiming to develop clean medicinal areas that meet GACP-WHO standards, in order to protect natural resources and ensure a stable and sustainable supply for the Company's oriental medicinal products.

Traphaco's success with its high-end oriental medicine products comes not only from high-quality raw materials, but also from strong investment in modern, environmentally friendly production technology. Traphaco owns a GMP-certified factory system with advanced technology, helping to ensure consistent product quality, thereby enhancing the brand's reputation. Traphaco's oriental medicine products, such as Boganic and Hoat Huyet Duong Nao, meet the healthcare needs of domestic consumers and gradually affirm their position in the international market.

Developing high-quality oriental medicine - the journey to preserve national resources

Vietnam has abundant medicinal resources, with valuable medicinal plants of great value in traditional medicine. Traphaco understands its role not only as a manufacturing enterprise, but also as a custodian and developer of the nation's cultural and medical values. Therefore, the Company has invested in standard medicinal areas, cooperated with local farmers, trained and provided techniques so that people can grow and harvest medicinal herbs sustainably, protecting natural resources.

Traphaco currently owns 10 medicinal herb areas that meet GACP-WHO standards across the country, specializing in providing abundant and quality raw materials for the Company's key products. A typical example is the artichoke growing area in Sapa, where Traphaco has invested in cultivation techniques and plant varieties, helping people not only increase their income, but also contribute to preserving a valuable medicinal resource.

From the foundation of prestigious products such as Boganic or Hoat huyet duong nao, Traphaco innovates formulas, combines new active ingredients to create high-end oriental medicine products, making the most of the value of natural medicinal herbs of Vietnam.

With high-end oriental medicine, Traphaco team constantly researches and studies to create an "upgrade" with Premium product line - Traphaco's typical high-end oriental medicine line with 3 characteristics: quintessence (East-West combination formula, standardized medicinal source), modern (technology, clinical research, packaging), sustainable (environmental protection and contribution to the community).

High quality pharmaceuticals - when science is for the community

Realizing the increasing market demand for modern pharmaceutical products, Traphaco has boldly invested in research and development of this product line. The company has built a smart modern pharmaceutical factory with strict quality standards, using robots in the production process to ensure consistent quality.

In addition, Traphaco also cooperates with Daewoong, one of the leading pharmaceutical corporations in Korea, to transfer technology, helping to improve the quality of pharmaceutical products and reduce treatment costs for patients.

Traphaco's new pharmaceutical products, such as new generation anticoagulants and lipid disorder treatments, have been recognized by the Ministry of Health as meeting bioequivalence standards with generic drugs. Since the beginning of 2022, Traphaco has had 10 products declared bioequivalent by the Ministry of Health. This is a proud achievement and a favorable first step to make the Traphaco brand stronger on the map of pharmaceutical manufacturers in Vietnam.

This not only helps Vietnamese consumers access high-quality products at reasonable costs, but also contributes to improving Traphaco's competitiveness in the international market. With a strategy of developing high-quality pharmaceuticals, Traphaco hopes to contribute to reducing medical costs and expanding access to quality medical services for people.

Social responsibility and sustainable development - Traphaco's strong commitment

In addition to focusing on business development, Traphaco also actively participates in social activities and environmental protection. Traphaco strictly adheres to ESG (environmental, social, governance) standards, commits to minimizing negative impacts on the environment and actively contributes to community development. The company has implemented many environmental protection projects, such as waste management and emission reduction at factories, as well as encouraging the use of environmentally friendly raw materials.

Through the GreenPlan Project, Traphaco not only helps improve the lives of local people, but also contributes to creating a green and sustainable living environment. The development of medicinal areas brings economic benefits, while helping to preserve biodiversity and protect Vietnam's precious medicinal plants. In particular, Traphaco has built a linkage model led by ethnic minority women, helping to enhance the role of women in the community and promote gender equality.

Affirming Vietnamese brand

At the 2024 General Meeting of Shareholders, Traphaco's Board of Directors expressed the Company's great determination in the field of technology transfer and exporting Traphaco products to international markets.

Regarding technology transfer, Traphaco will receive innovative products from Daewoong (Korea), including NCE (new pharmaceutical ingredients), combination drugs, suspensions and functional food products. In addition, Traphaco also plans to build new brands through technology transfer in consumer products, such as Impactamin (multivitamin), Daewoong's most famous brand in Korea.

The Korean members of Traphaco's Board of Directors and their team will seek potential opportunities to enhance Traphaco's overseas capabilities by bringing Traphaco's blockbuster products such as Boganic, Hoat Huyet Duong Nao, and Methorphan to Southeast Asian countries and beyond.

Source: https://baodautu.vn/traphaco-kien-dinh-voi-chien-luoc-song-hanh-dong-duoc---tan-duoc-d230087.html